NTRA
Natera, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$262.63-3.23%
Price as of Jul 20, 2026
NTRA valuation
Natera, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 201.77x
- P/S forward
- 13.06x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.20x
- Price / sales
- 15.04x
- Price / cash flow
- 178.24x
Enterprise value
- Enterprise value
- $36.8B
- EV / sales
- 14.70x
- EV / EBITDA
- -164.30x
- EV / EBIT
- -113.38x
- Market cap
- $37.6B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.